CBD tested as shield against Chemo's nerve pain
NCT ID NCT07167446
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial tests whether taking CBD capsules can prevent nerve damage caused by the chemotherapy drug oxaliplatin in people with colorectal cancer. Thirty participants will be randomly assigned to receive either CBD plus standard chemo or chemo alone. The main goal is to see if patients can stick with the CBD regimen, not yet to prove it works.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cannabidiol (CBD) capsules
What this could lead to
If it works, this could point toward a way to prevent painful nerve damage from chemotherapy, improving quality of life for cancer patients.
What could go wrong
This is a very early, small pilot study with only 30 people. It mainly tests feasibility, not effectiveness. CBD may not prevent neuropathy, and side effects or interactions with chemo are possible.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL NEUROPATHY DUE TO CHEMOTHERAPY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fox Chase Cancer Center
RECRUITINGPhiladelphia, Pennsylvania, 19111, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••